As of the market close on Friday, my portfolio is up 2.81% on weekly basis, above the return of 0.53% from my benchmark NQ US Sm Cap Biotech Index.
My portfolio is up 19.67% slightly above my benchmark (15.60%) since kick-off 2017/08/18. This week we hit 300K again.
Of the current 7 stocks in the portfolio, only one stock is down (NASDAQ:MRSN), 2 (NASDAQ:SRPT)(NASDAQ:LOXO) are up, 4 are flat (±3%) (NASDAQ:FOLD)(NASDAQ:JAZZ)(NASDAQ:MNK)(NASDAQ:TRVN).
This week I've closed LOXO and SRPT and added ABUS, AXON, FCSC and RDHL.